ImmunityBio, Inc.
IBRX
$2.13
$0.010.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.34% | 28.61% | -119.14% | 30.99% | 36.29% |
| Total Depreciation and Amortization | 1.83% | 1.33% | -7.47% | -7.12% | 1.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -19.23% | 6.29% |
| Total Other Non-Cash Items | -53.55% | -76.62% | 355.08% | -78.07% | -173.26% |
| Change in Net Operating Assets | -122.04% | 74.79% | -103.24% | -7.88% | -287.40% |
| Cash from Operations | 13.59% | 7.17% | -0.89% | 13.79% | 1.58% |
| Capital Expenditure | 31.45% | 3.57% | 46.90% | 24.39% | -285.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,099.26% | -386.88% | -56.05% | -82.39% | 233.60% |
| Cash from Investing | -1,023.53% | -490.94% | -58.01% | -84.88% | 226.30% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -200.00% | -- | -- | 100.00% | -4.76% |
| Issuance of Common Stock | 0.32% | 78,598.18% | -99.80% | 577.43% | -69.68% |
| Repurchase of Common Stock | 53.11% | 73.21% | -49.69% | -168.56% | 39.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -200.00% |
| Cash from Financing | 0.41% | 17,697.76% | -100.92% | 586.23% | -89.53% |
| Foreign Exchange rate Adjustments | -173.68% | 860.00% | -42.86% | -163.64% | -8.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.75% | 193.03% | -361.82% | 274.29% | -518.83% |